- On-Demand
Episode 1 of 4 - The Evolution of Biomarker Testing: Revolutionizing Treatment of NSCLC
- Credit: 0.30hr(s)
- NCPD
- November 22, 2022 —
- November 28, 2023
- Therapeutic Areas: Hematologic Oncology, Oncology
- Specialties: Biomarkers, NSCLC
- Location: Internet Activity Enduring
Biomarker testing can have a significant impact on the treatment plan of patients with non-small cell lung cancer (NSCLC). In this first episode of the 4-part educational initiative Biomarker-based Therapy for NSCLC: Improving Collaboration, Communication, and Care, expert faculty apply the latest clinical guidelines and give practical tips on breaking down barriers for oncology teams to successfully implement biomarker testing for NSCLC patients, including those in underserved populations.